Literature DB >> 16670164

The relationship between libido and testosterone levels in aging men.

Thomas G Travison1, John E Morley, Andre B Araujo, Amy B O'Donnell, John B McKinlay.   

Abstract

CONTEXT: Although it is known that serum testosterone (T) concentrations are related to libido, the strength of that relationship in community-dwelling men has not yet been determined.
OBJECTIVE: Our objective was to assess the strength and significance of the association between aging men's self-reports of libido and serum T concentrations.
DESIGN: Our study was a community-based evaluation of men's health and aging, including three data collection waves: baseline (T1, 1987-1989) and follow-ups (T2, 1995-1997; T3, 2002-2004). Libido was measured on a 14-point scale assessing self-reported frequency of desire and thoughts/fantasies; low libido was defined as a score of less than 7 of 14.
SETTING: We conducted an epidemiological study in greater Boston, Massachusetts. PARTICIPANTS: There were 1632 men aged 40-70 yr at baseline, with follow-up on 922 (56%) at 9 yr (T2) and 623 (38%) at 15 yr (T3). MAIN OUTCOME MEASURES: We assessed total and calculated bioavailable T .
RESULTS: Three hundred eighteen (19%) subjects reported low libido at baseline. Libido and T displayed a significant association. However, the difference in mean T levels between those subjects with low libido and those without was small; analyses indicated a 3.4 ng/dl (0.12 nmol/liter) increase in total T per unit increase in libido. Subjects reporting low libido exhibited an increased but modest probability of exhibiting low T. Dividing T concentrations by the number of androgen receptor gene cytosine, adenine, guanine repeats did not enhance associations.
CONCLUSIONS: Libido and T concentrations are strongly related at the population level. However, the value of individual patient reports of reduced libido as indicators of low T levels is open to question.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670164     DOI: 10.1210/jc.2005-2508

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  36 in total

Review 1.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

Review 2.  [Is there a pharmacotherapy for libido disturbances in men?].

Authors:  F-M Köhn
Journal:  Urologe A       Date:  2006-08       Impact factor: 0.639

Review 3.  Functional significance of the rapid regulation of brain estrogen action: where do the estrogens come from?

Authors:  Charlotte A Cornil; Gregory F Ball; Jacques Balthazart
Journal:  Brain Res       Date:  2006-09-15       Impact factor: 3.252

Review 4.  Aging and sex hormones in males.

Authors:  Maria Chiara Decaroli; Vincenzo Rochira
Journal:  Virulence       Date:  2016-11-10       Impact factor: 5.882

Review 5.  Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea.

Authors:  Young Hwii Ko; Je Jong Kim
Journal:  Asian J Androl       Date:  2011-05-16       Impact factor: 3.285

6.  The natural history of symptomatic androgen deficiency in men: onset, progression, and spontaneous remission.

Authors:  Thomas G Travison; Rebecca Shackelton; Andre B Araujo; Susan A Hall; Rachel E Williams; Richard V Clark; Amy B O'Donnell; John B McKinlay
Journal:  J Am Geriatr Soc       Date:  2008-05       Impact factor: 5.562

7.  Increased sexual desire with exogenous testosterone administration in men with obstructive sleep apnea: a randomized placebo-controlled study.

Authors:  K L Melehan; C M Hoyos; B J Yee; K K Wong; P R Buchanan; R R Grunstein; P Y Liu
Journal:  Andrology       Date:  2015-11-26       Impact factor: 3.842

8.  Pharmacologically induced hypogonadism and sexual function in healthy young women and men.

Authors:  Peter J Schmidt; Emma M Steinberg; Paula Palladino Negro; Nazli Haq; Carolyn Gibson; David R Rubinow
Journal:  Neuropsychopharmacology       Date:  2008-03-19       Impact factor: 7.853

9.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

10.  Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations.

Authors:  C Wang; E Nieschlag; R Swerdloff; H M Behre; W J Hellstrom; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; A Morales; J E Morley; C Schulman; I M Thompson; W Weidner; F C W Wu
Journal:  Eur J Endocrinol       Date:  2008-11       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.